Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guru Sonpavde

Showing results (1-10 of 402) with videos related to

Pageof 41
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 20, 2016
Reply to L.J. Eapen et alGuru Sonpavde
The New England Journal of Medicine|February 18, 2017
PD-1 and PD-L1 Inhibitors as Salvage Therapy for Urothelial CarcinomaGuru Sonpavde
Current Opinion in Urology|August 9, 2017
The biology of prostate cancer metastases: does oligo differ from polymetastatic?Guru Sonpavde
Oncology (Williston Park, N.Y.)|June 17, 2016
Systemic Therapy for Urothelial Carcinoma: Is a Renaissance Around the Corner?Guru Sonpavde
The New England Journal of Medicine|October 24, 2003
Bevacizumab in renal-cell cancerGuru Sonpavde
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2003
Communicating the value of adjuvant chemotherapyGuru Sonpavde
The New England Journal of Medicine|August 21, 2004
Treatment of advanced head and neck cancerGuru Sonpavde
The New England Journal of Medicine|August 26, 2011
Abiraterone and increased survival in metastatic prostate cancerGuru Sonpavde
The New England Journal of Medicine|September 24, 2005
Radical prostatectomy versus watchful waitingGuru Sonpavde
The New England Journal of Medicine|March 31, 2007
Bevacizumab for non-small-cell lung cancerGuru Sonpavde
Pageof 41

Showing results (1-10 of 402) with videos related to

Sort By:
Pageof 41
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 20, 2016
Reply to L.J. Eapen et alGuru Sonpavde
The New England Journal of Medicine|February 18, 2017
PD-1 and PD-L1 Inhibitors as Salvage Therapy for Urothelial CarcinomaGuru Sonpavde
Current Opinion in Urology|August 9, 2017
The biology of prostate cancer metastases: does oligo differ from polymetastatic?Guru Sonpavde
Oncology (Williston Park, N.Y.)|June 17, 2016
Systemic Therapy for Urothelial Carcinoma: Is a Renaissance Around the Corner?Guru Sonpavde
The New England Journal of Medicine|October 24, 2003
Bevacizumab in renal-cell cancerGuru Sonpavde
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2003
Communicating the value of adjuvant chemotherapyGuru Sonpavde
The New England Journal of Medicine|August 21, 2004
Treatment of advanced head and neck cancerGuru Sonpavde
The New England Journal of Medicine|August 26, 2011
Abiraterone and increased survival in metastatic prostate cancerGuru Sonpavde
The New England Journal of Medicine|September 24, 2005
Radical prostatectomy versus watchful waitingGuru Sonpavde
The New England Journal of Medicine|March 31, 2007
Bevacizumab for non-small-cell lung cancerGuru Sonpavde
Pageof 41